Genetic roadmap for metastatic breast cancer: CATCH trial aims to match patients to targeted therapies
NCT ID NCT05652569
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
The CATCH trial is a large observational study for people with metastatic breast cancer. It uses advanced genetic testing on tumor biopsies to find unique biomarkers and drug targets. The goal is to create a precision medicine platform that helps guide patients toward the most promising clinical trials and targeted treatments. This study does not test a new drug itself but aims to improve how treatments are chosen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this platform could help match more metastatic breast cancer patients with targeted therapies and clinical trials tailored to their tumor's genetic profile.
What could go wrong
This is an observational diagnostic study, not a treatment trial. It may not directly improve outcomes, and genomic profiling may not always find actionable targets.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Caritas Hospital St. Josef
RECRUITINGRegensburg, Germany
Contact
-
Charité
RECRUITINGBerlin, Germany
Contact
-
Medical Faculty and University Hospital Carl Gustav Carus
RECRUITINGDresden, Germany
Contact
-
National Center for Tumor Diseases
RECRUITINGHeidelberg, Germany
Contact
-
Robert-Bosch-Krankenhaus Stuttgart
RECRUITINGStuttgart, Germany
Contact
-
University Hospital Augsburg
RECRUITINGAugsburg, Germany
Contact
-
University Hospital Erlangen
RECRUITINGErlangen, Germany
Contact
-
University Hospital Essen
RECRUITINGEssen, Germany
Contact
-
University Hospital Köln
RECRUITINGCologne, Germany
Contact
Contact
-
University Hospital Tübingen
RECRUITINGTübingen, Germany
Contact
-
University Hospital Ulm
RECRUITINGUlm, Germany
Contact
-
University Hospital Würzburg
RECRUITINGWürzburg, Germany
Contact
Contact